Effect of Acarbose on Long-Term Prognosis in Acute Coronary Syndromes Patients with Newly Diagnosed Impaired Glucose Tolerance

Table 2

MACE among the study patients in the mean 2.3-year follow-up (, %).

	Control group; ()	Acarbose group; ()
Cardiovascular death, (%)	5 (7.81)	3 (5.00)
Nonfatal reinfarction, (%)	7 (10.94)	2 (3.33)
New-onset angina, (%)	9 (14.06)	5 (8.33)
Cerebral stroke, (%)	4 (6.25)	2 (3.33)
Severe heart failure, (%)	5 (7.81)	4 (6.67)
Total MACE, (%)	30 (46.88)	16 (26.67)

MACE: major adverse cardiovascular events.